“With donor support flagging around the world, U.S. leadership is crucial. Congress must fully fund its global health programs, especially the Global Fund” to Fight AIDS, Tuberculosis and Malaria, Joyce Kamwana, a Global Fund “HERE I AM” campaign ambassador, writes in The Hill’s “Congress Blog.” She adds, “Reducing support for global health would put millions of people at risk” and “would deal a devastating blow to the global fight against AIDS, which has reached a critical point.”
This Lancet editorial responds to the 25th Board meeting of the Global Fund to Fight AIDS, Tuberculosis and Malaria held in Accra, Ghana in November, stating, “Tensions were high as the Fund had to make difficult decisions in a year that has been plagued by financial shortfalls, corruption, and calls for organizational reforms. â€¦ However, the Fund remains committed to ensuring the continuation of essential services and to supporting existing grants over new ones to the end of 2013.”
The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria decided to cancel Round 11 grant approval during a two-day meeting in Accra, Ghana, that concluded on November 22, according to a Global Fund press release (11/23). The following opinion pieces address this action.
The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria decided to cancel Round 11 grant approval during a two-day meeting in Accra, Ghana, that concluded on November 22. According to a press release from the Global Fund, the decision to cancel Round 11 was due to “a revised resource forecast presented to the Board [which] showed that substantial budget challenges in some donor countries, compounded by low interest rates, have significantly affected the resources available for new grant funding.”
In this Financial Times opinion piece, journalist Andrew Jack examines how, “[a]fter a period of fast expansion, and strong progress in tackling AIDS, [tuberculosis (TB)] and malaria alike,” the Global Fund to Fight AIDS, Tuberculosis and Malaria “has become a target in the era of austerity. With a shift in power between the world’s traditional and emerging economies, and donors seeking ways to cut support, billions of dollars and millions of lives are at stake.” Jack recaps a brief history of the Fund in the 10 years since its inception; highlights a number of ways in which the Fund has been distinctive from other organizations; and notes several issues that have led to calls for reform within the Fund.
The vision of an “AIDS-free generation” presented in a speech earlier this month by Secretary of State Hillary Rodham Clinton “is under threat in Congress,” as “[t]he House and the Senate are discussing significant cuts to the 2012 Obama administration request for global health funding,” Jeanie Yoon, a physician with Doctors Without Borders/Medecins Sans Frontieres (MSF), writes in a Baltimore Sun opinion piece. Yoon describes an MSF program in Zambia working to prevent mother-to-child HIV transmission (PMTCT), saying such programs “provide an opportunity for mothers be tested for HIV (as well as other dangerous conditions for pregnant women) and to take the steps needed for them and their babies to live healthy lives; as well as for communities to gain productive members instead of incurring yet more losses.”
While the recent report from a High-Level Independent Review Panel of the Global Fund to Fight AIDS, Tuberculosis and Malaria, “and the corresponding decisions of the Board, mark an important step towards the necessary improvements the Global Fund must make to fulfill its vital mandate in the coming decade and beyond,” “the report does not provide direction or solutions on certain critical issues that will define the further success and impact of the Global Fund,” Richard Feachem, founding executive director of the Global Fund, writes in a Lancet commentary.
Aid Targeting High Mortality Diseases ‘Lays The Groundwork’ For Improving Primary Health Care Services
“In recent years, initiatives such as the President’s Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund to Fight AIDS, Tuberculosis, and Malaria have helped rein in some of the biggest scourges,” Paul Farmer, co-founder of Partners in Health and chair of the Department of Global Health and Social Medicine at Harvard Medical School, writes in a Washington Post opinion piece. “Scaling up PEPFAR, alongside other health initiatives, would bring a high return,” because “as we deepen the response to specific diseases such as AIDS or TB, we can broaden access to primary health services,” which “lays the groundwork for addressing health problems of all kinds,” he continues.
“Sony Corporation and the Global Fund to Fight AIDS, Tuberculosis and Malaria have entered into a partnership for the implementation of behavior change projects, in which Sony provides state of the art equipment and movies and the Global Fund ensures it gets to agencies best able to reach communities most…
In response to Michael Gerson’s November 11 column in which he said the end of AIDS is possible because of combination prevention and treatment innovations, David Bryden, the Stop TB advocacy officer at RESULTS, writes in a Washington Post letter to the editor, “Another benefit of [HIV] treatment is that it sharply reduces deaths from tuberculosis [TB], which is the primary killer of people living with HIV/AIDS.” He says that “to fully succeed in Africa, where TB and HIV/AIDS are often two sides of the same coin, we have to quickly identify people who have TB or who are vulnerable to it and get them the services they need,” which also means developing an accurate quick test for the disease.